๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease

RecruitingNAAges 5 Years - 16 YearsAllInsel Gruppe AG, University Hospital Bern
NCT05504928 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The overall objective is to evaluate the effectiveness of a school-centered primary and secondary prevention program on the prevalence of latent rheumatic heart disease among schoolchildren in Nepal, and to investigate the role of socioeconomic and environmental factors in the development and progression of rheumatic heart disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 5-16 years * Attending Tulsi Secondary Boarding School in Tulsipur, Nepal. Exclusion Criteria: * Children / primary caregivers not providing informed consent to participate * Children not attending Tulsi Secondary Boarding School in Tulsipur.
๐Ÿ’Š

What it tests

  • School nurse program
๐Ÿ“

Where

1 site
Tulsi Secondary Boarding School
Tulsiฬ‡ฬ„pur, Nepal
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy